New Cases of Ebola Reported in the DRC
New cases of Ebola were confirmed in the North Kivu Province, just 1 week after the outbreak in the Equator Province ended.
UK Health Officials Aim to Stop the Emerging Superbug Mycoplasma Genitalium
Better diagnostics and treatment are needed for Mycoplasma genitalium—a lesser-known sexually-transmitted infection estimated to infect up to 3% of the population in many countries.
Consensus Statement Seeks to Halt Criminalization of HIV—Public Health Watch
Science doesn’t support legal punishment of HIV-positive people.
Post-Eculizumab Meningococcal Disease in A Vaccinated Patient
A recent report shows that patients receiving eculizumab remain extremely susceptible to meningococcal disease, including from nongroupable Neisseria meningitidis strains, despite being vaccinated against the disease.
Colistin-Resistant MCR-1 Genes Found in Bacteria on Hospital Surfaces
New data reveals that mcr-1 carrying Enterobacteriaceae can be detected on hospital surfaces, indicating that this plasmid has the ability to spread in key human pathogens.
HIV Testing Programs Needed in Southern US to Improve Black MSM Linkage to Care
A new CDC analysis underscores the need for HIV testing programs in the southern part of the United States to improve linkage medical care among HIV-positive black men who have sex with men (MSM).
Clade X Simulation Reveals United States is Not Prepared for Severe Pandemics
A simulation exercise conducted by the Johns Hopkins Center for Health Security emphasizes the need for new policies and procedures to reduce negative outcomes in future pandemics.
Legionella Bacteria Detected in Two New York City Boroughs
Legionella bacteria were detected in the water supply of a Bronx hospital as cases of Legionnaires’ disease rise in Lower Washington Heights cluster.
Changes to CMS IPPS: What Does It Mean for Infection Prevention Programs?
Requiring reporting of health care-associated infections for reimbursement is a lot messier than one might think.
Recalls You Should Know About—Week of July 22, 2018
We’ve rounded up a list of important US Food and Drug Administration (FDA) recalls from this week.
Hepatitis A Outbreak in Kentucky is Not Over Yet
Since August of 2017, there have been 1,170 cases of hepatitis A in Kentucky, resulting in 658 hospitalizations and 8 deaths.
Herpes Shedding Rate Can Stand in For Genital Lesions as a Study Outcome
Genital shedding in herpes patients is even more common than genital lesions. Can a new way of testing for the disease streamline the treatment process?
Obstructive Sleep Apnea is Largely Untreated in HIV Patients
OSA is largely untreated in HIV patients, and this lack of treatment likely contributes to further comorbidity complications associated with the virus.
For Hospitals, Going Green Is an Infection Prevention Issue
As more and more health care organizations embrace environmental sustainability, experts say epidemiologists need to have a seat at the table to stave off infection control and prevention concerns.
FDA Investigates Whey Powder As Potential Source of Salmonella Contamination
The FDA has indicated that whey powder is a common ingredient in 3 products recalled this week for potential Salmonella contamination.
The Frustrating Predicament of PPE Compliance
We know we have a problem with isolation precaution compliance, but just how bad is it?
HCV Eradication in HIV Patients Reduces Immune Activation, HIV DNA
Eradication of HCV in patients with HIV results in reduction of CD4+ and CD8+ T cell immune activation.
Doravirine Maintains Efficacy in Week 96 DRIVE-FORWARD Results
At week 96, 73.1% of patients infected with HIV-1 and treated with once-daily doravirine + other ART medications, achieved viral suppression.
Using A "Kick and Kill" Approach to Cure HIV
Investigators report results of the first randomized clinical trial to test a novel strategy to wake up and kill dormant HIV hiding in reservoir cells.
Identifying—and Treating—the "Missing Millions" on World Hepatitis Day: Public Health Watch
Millions with viral hepatitis go undiagnosed and untreated.
2-Drug HIV Regimen Comparable to 3-Drug Regimen in Treatment-Naïve Patients
Dolutegravir and lamivudine combination regimen met primary endpoint in 2 phase 3 studies of treatment-naïve patients with HIV.
WHO Declares End of 2018 DRC Ebola Outbreak
After 42 days without any new confirmed cases, the ninth Ebola outbreak in the Democratic Republic of the Congo is officially over.
Long-Term Immune Response Data for Investigational HIV Vaccine Revealed
Mosaic-based vaccine regimen maintained humoral and cellular HIV immune responses according to long-term data from APPROACH.
IAS-USA Releases 2018 Guidelines for HIV Treatment and Prevention
New guidelines on the prevention and treatment of HIV in adults from the IAS-USA Panel highlight advances made since the 2016 guidelines, as well as the need for new strategies.
Achieving Undetectable Viral Load On ART Renders Individuals Sexually Non-Infectious
PARTNER 2 study reports zero HIV transmissions over 8 years in gay couples who did not use condoms and had achieved an undetectable viral load on HIV treatment.
Ritonavir-Boosted Protease Inhibitors May Increase Risk of Cardiovascular Disease, Death
More information continues to come to light on the impact of protease inhibitors on patients with HIV and cardiovascular disease.
Alleged Penicillin Allergies Lead to Higher Risk of MRSA and C difficile
Alternative agents are often broader spectrum than ß-lactams, subjecting patients to collateral damage and subsequent selection for resistant organisms and Clostridium difficile.
PrEP Use May Result in Increased Receipt of Non-HIV-Related Primary Care
A new study reports that PrEP users were more likely to receive more primary health care services compared with non-PrEP users.
FDA Approves Tafenoquine, First New P Vivax Malaria Treatment in 60 Years
Tafenoquine is the first single-dose medicine for the prevention of P vivax malaria relapse.
Recalls You Should Be Aware Of—Week of July 15,2018
We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.